BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 377711)

  • 1. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
    Hirschberg H; Moen T; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial-monocyte antigens.
    Stastny P
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):32-6. PubMed ID: 7001701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRw alloantigens can be detected on peripheral blood T lymphocytes.
    Mann DL; Sharrow SO
    J Immunol; 1980 Nov; 125(5):1889-96. PubMed ID: 7000892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific destruction of human endothelial cell monolayers by anti-DRw antisera.
    Hirschberg H; Moen T; Throsby E
    Transplantation; 1979 Aug; 28(2):116-20. PubMed ID: 483358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies eluted from rejected human renal allografts: specificity to B lymphocytes, monocytes, primary kidney cells, and endothelial cells.
    Lee HM; Waldrep JC; Mendez-Picon G; Mohanakumar T
    Transplant Proc; 1981 Mar; 13(1 Pt 1):108-10. PubMed ID: 7022806
    [No Abstract]   [Full Text] [Related]  

  • 7. Human endothelial cell antigens: molecular independence from HLA and expression in blood monocytes.
    Moraes JR; Stastny P
    Transplant Proc; 1977 Mar; 9(1):605-7. PubMed ID: 325796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial antibodies in renal transplantation.
    Paul LC; van Es LA; Claas FH; Kalff MW
    Proc Eur Dial Transplant Assoc; 1979; 16():431-6. PubMed ID: 398516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic correlates of human renal allograft survival.
    Etheredge EE; Sicard GA; Anderson CB
    Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactions of kidney cells with cytotoxic antisera: possible evidence of kidney-specific antigens.
    Perkins HA; Gantan Z; Siegel S; Howell E; Belzer FO; Kountz SL
    Tissue Antigens; 1975 Apr; 5(2):89-98. PubMed ID: 1093285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
    Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial monocyte antigens in man.
    Stastny P
    Transplant Proc; 1978 Dec; 10(4):875-7. PubMed ID: 366834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
    Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
    Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.